| Visualizaciones | |
|---|---|
| Importance of the identification of the CYP3A4*2 polymorphism for the prescription of pharmacological treatment | 151 |
| agosto 2025 | septiembre 2025 | octubre 2025 | noviembre 2025 | diciembre 2025 | enero 2026 | febrero 2026 | |
|---|---|---|---|---|---|---|---|
| Importance of the identification of the CYP3A4*2 polymorphism for the prescription of pharmacological treatment | 0 | 0 | 0 | 0 | 0 | 14 | 0 |
| Visualizaciones | |
|---|---|
| 0970-938X-19-273 Galeras pdf CYP.pdf | 112 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 59 |
| Canadá | 19 |
| Alemania | 13 |
| México | 12 |
| EU | 10 |
| Ghana | 4 |
| Rusia | 4 |
| China | 3 |
| Ucrania | 3 |
| Lituania | 2 |
| Visualizaciones | |
|---|---|
| Ottawa | 13 |
| Kiez | 11 |
| Secaucus | 11 |
| Oakland | 8 |
| Palo Alto | 7 |
| Falls Church | 6 |
| Toronto | 6 |
| Mexico | 4 |
| Wilmington | 4 |
| Jacksonville | 3 |